We are live on
!
Find out more
ASA
Armstrong Shaw Associates Portfolio holdings
AUM
$95.2M
1-Year Est. Return
23.67%
This Fund
S&P 500
This Quarter
Est. Return
-14.77%
1 Year Est. Return
+23.67%
3 Year Est. Return
+51.2%
5 Year Est. Return
+82.8%
10 Year Est. Return
+225.63%
AUM
$99.3M
AUM Growth
-$20.3M
(-17%)
Cap. Flow
-$760K
Cap. Flow
% of AUM
-0.77%
Top 10 Holdings %
Top 10 Hldgs %
62.63%
Holding
43
New
–
Increased
–
Reduced
3
Closed
1
Top Buys
No buys this quarter
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$318K |
| 2 |
Zimmer Biomet
ZBH
|
+$243K |
| 3 |
UnitedHealth
UNH
|
+$188K |
| 4 |
Microsoft
MSFT
|
+$10.9K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 21.99% |
| 2 | Healthcare | 21.8% |
| 3 | Financials | 20.54% |
| 4 | Communication Services | 9.44% |
| 5 | Consumer Discretionary | 6.53% |
Similar funds
AEPLI
GG
VI
TAM
WCM
QT
OC
KC
Armstrong Shaw Associates's Q2 2022 Portfolio in Review
As of Q2 2022, Armstrong Shaw Associates held 43 positions worth $99.3M, down 17% from $120M the previous quarter. Its ten largest holdings account for 63% of the portfolio.
Trading was light in Q2 2022: portfolio turnover was 2.3%. Armstrong Shaw Associates opened no new positions and exited 1, leaving the 43-position portfolio largely intact.
By sector, the portfolio is most concentrated in Technology at 22% of assets, down from 23% a quarter earlier, followed by Healthcare and Financials.
- Armstrong Shaw Associates's biggest Q2 2022 reduction was Apple, cutting an estimated $318K.
- Armstrong Shaw Associates fully exited Zimmer Biomet in Q2 2022, selling an estimated $243K.
- Armstrong Shaw Associates's ten largest holdings make up 63% of its $99.3M portfolio in Q2 2022.
- Armstrong Shaw Associates opened 0 new positions and closed 1 in Q2 2022.
- Armstrong Shaw Associates's portfolio value fell 17% quarter-over-quarter to $99.3M.
Based on Armstrong Shaw Associates's 13F filing for Q2 2022, filed 26 Jul 2022.